122 related articles for article (PubMed ID: 35484754)
1. Mechanism for Bioactive Nanomaterial circ0024831 Regulation of Staphylococcal Nuclease Domain Containing 1 via RNA Methylation Recognition in Osteosarcoma.
Zheng H; Wang J; Zhang W; He B; Wang Y; Zhang X; Mao H; Fan L
J Biomed Nanotechnol; 2022 Feb; 18(2):453-462. PubMed ID: 35484754
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
[TBL] [Abstract][Full Text] [Related]
3. Methyltransferase-like 3 enhances cell proliferation and cisplatin resistance in natural killer/T-cell lymphoma through promoting N6-methyladenosine modification and the stability of staphylococcal nuclease and Tudor domain-containing protein 1 mRNA.
Li N; Wei J; Zhang Q; Zhang Q; Liu B
Anticancer Drugs; 2023 Jun; 34(5):627-639. PubMed ID: 36730541
[TBL] [Abstract][Full Text] [Related]
4. SND1 promotes the proliferation of osteosarcoma cells by upregulating COX‑2/PGE2 expression via activation of NF‑κB.
Zhou M; Wang A; Yin B; Wu D; Han S; Zhang W; Liu J; Sun K
Oncol Rep; 2019 Jan; 41(1):579-589. PubMed ID: 30365124
[TBL] [Abstract][Full Text] [Related]
5. N-Glycosylation on Asn50 of SND1 Is Required for Glioma U87 Cell Proliferation and Metastasis.
Zhou Y; Li Q; Zheng J; Lin N
J Immunol Res; 2022; 2022():5239006. PubMed ID: 36213325
[TBL] [Abstract][Full Text] [Related]
6. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma.
Wright T; Wang Y; Stratton SA; Sebastian M; Liu B; Johnson DG; Bedford MT
Biochem J; 2023 Nov; 480(22):1805-1816. PubMed ID: 37905668
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
[TBL] [Abstract][Full Text] [Related]
8. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).
Jariwala N; Rajasekaran D; Srivastava J; Gredler R; Akiel MA; Robertson CL; Emdad L; Fisher PB; Sarkar D
Int J Oncol; 2015 Feb; 46(2):465-73. PubMed ID: 25405367
[TBL] [Abstract][Full Text] [Related]
9. Tudor Staphylococcal Nuclease plays two antagonistic roles in RNA metabolism under stress.
Gutiérrez-Beltran E; Bozhkov PV; Moschou PN
Plant Signal Behav; 2015; 10(10):e1071005. PubMed ID: 26237081
[TBL] [Abstract][Full Text] [Related]
10. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.
Cui X; Zhao C; Yao X; Qian B; Su C; Ren Y; Yao Z; Gao X; Yang J
RNA Biol; 2018; 15(10):1364-1375. PubMed ID: 30321081
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular insights into the role of SND1 in lipid metabolism.
Navarro-Imaz H; Ochoa B; García-Arcos I; Martínez MJ; Chico Y; Fresnedo O; Rueda Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158589. PubMed ID: 31978555
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain.
Liu K; Chen C; Guo Y; Lam R; Bian C; Xu C; Zhao DY; Jin J; MacKenzie F; Pawson T; Min J
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18398-403. PubMed ID: 20937909
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.
Kuruma H; Kamata Y; Takahashi H; Igarashi K; Kimura T; Miki K; Miki J; Sasaki H; Hayashi N; Egawa S
Am J Pathol; 2009 Jun; 174(6):2044-50. PubMed ID: 19435788
[TBL] [Abstract][Full Text] [Related]
14. Posttranscriptional Inhibition of Protein Tyrosine Phosphatase Nonreceptor Type 23 by Staphylococcal Nuclease and Tudor Domain Containing 1: Implications for Hepatocellular Carcinoma.
Jariwala N; Mendoza RG; Garcia D; Lai Z; Subler MA; Windle JJ; Mukhopadhyay ND; Fisher PB; Chen Y; Sarkar D
Hepatol Commun; 2019 Sep; 3(9):1258-1270. PubMed ID: 31497746
[TBL] [Abstract][Full Text] [Related]
15. NF-κB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene.
Armengol S; Arretxe E; Rodríguez L; Ochoa B; Chico Y; Martínez MJ
Biochimie; 2013 Apr; 95(4):735-42. PubMed ID: 23160072
[TBL] [Abstract][Full Text] [Related]
16. Identification of Small Inhibitors for Human Metadherin, an Oncoprotein, through
Khattak AA; Ahmad A; Khattak HA; Irshad Khan MZ
Curr Comput Aided Drug Des; 2023; 19(4):278-287. PubMed ID: 36627784
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in m6A modification genes are associated with colorectal cancer risk.
Meng Y; Li S; Gu D; Xu K; Du M; Zhu L; Chu H; Zhang Z; Wu Y; Fu Z; Wang M
Carcinogenesis; 2020 Mar; 41(1):8-17. PubMed ID: 31579913
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
Shen M; Smith HA; Wei Y; Jiang YZ; Zhao S; Wang N; Rowicki M; Tang Y; Hang X; Wu S; Wan L; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):60-74. PubMed ID: 35121988
[TBL] [Abstract][Full Text] [Related]
19. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions.
Blanco MA; Alečković M; Hua Y; Li T; Wei Y; Xu Z; Cristea IM; Kang Y
J Biol Chem; 2011 Jun; 286(22):19982-92. PubMed ID: 21478147
[TBL] [Abstract][Full Text] [Related]
20. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
